b. KGD setelah perlakuan
Tests of Normality
Hari_ke Kolmogorov-Smirnov
a
Shapiro-Wilk Statistic
df Sig.
Statistic df Sig.
Aquades 3
.306 5
.143 .905 5 .438
6 .137
5 .200
.986 5 .965 9
.226 5
.200 .909 5 .464
12 .315
5 .118
.774 5 .049 15
.303 5
.150 .845 5 .179
Dosis_100 3
.203 5
.200 .903 5 .428
6 .271
5 .200
.920 5 .533 9
.290 5
.197 .910 5 .470
12 .377
5 .019
.796 5 .075 15
.273 5
.200 .886 5 .335
Dosis_200 3
.129 5
.200 .994 5 .992
6 .219
5 .200
.920 5 .528 9
.201 5
.200 .969 5 .870
12 .192
5 .200
.976 5 .911 15
.254 5
.200 .914 5 .492
Dosis_300 3
.307 5
.138 .770 5 .046
6 .345
5 .051
.733 5 .021 9
.327 5
.087 .801 5 .082
12 .318
5 .111
.797 5 .077 15
.285 5
.200 .859 5 .225
Metformin 3
.255 5
.200 .900 5 .413
6 .257
5 .200
.925 5 .565 9
.273 5
.200 .866 5 .249
12 .155
5 .200
.979 5 .931 15
.239 5
.200 .947 5 .716
Test of Homogeneity of Variances
Levene Statistic df1
df2 Sig.
Aquades 2.096
4 20
.119 Dosis_100
4.091 4
20 .014
Dosis_200 2.492
4 20
.076 Dosis_300
6.479 4
20 .002
Universitas Sumatera Utara
Metformin 9.297
4 20
.000
ANOVA
Sum of Squares
df Mean Square
F Sig.
Aquades Between Groups
91789.360 4
22947.340 1.939 .143 Within Groups
236697.200 20 11834.860
Total 328486.560 24
Dosis_200 Between Groups
157744.240 4
39436.060 6.701 .001 Within Groups
117698.000 20 5884.900
Total 275442.240 24
Kruskal-Wallis Test
Test Statistics
a,b
dosis100 dosis300
metformin Chi-Square
18.388 16.090
17.479 df
4 4
4 Asymp. Sig.
.001 .003
.002 a. Kruskal Wallis Test
b. Grouping Variable: Hari_ke
c. Perbandingan KGD sebelum induksi aloksan, hari ke-0 dan hari ke-15 setelah perlakuan
Tests of Normality
KGD Kolmogorov-Smirnov
a
Shapiro-Wilk Statistic
df Sig.
Statistic df Sig. Akuades
Sebelum .135
5 .200
.998 5 .998 Hari 0
.300 5
.161 .781 5 .056
Hari 15 .303
5 .150
.845 5 .179 Dosis_100
Sebelum .187
5 .200
.952 5 .749 Hari 0
.199 5
.200 .918 5 .517
Hari 15 .273
5 .200
.886 5 .335 Dosis_200 Sebelum
.293 5
.187 .916 5 .505
Universitas Sumatera Utara
Hari 0 .175
5 .200
.943 5 .685 Hari 15
.254 5
.200 .914 5 .492
Dosis_300 Sebelum
.258 5
.200 .939 5 .659
Hari 0 .267
5 .200
.893 5 .373 Hari 15
.285 5
.200 .859 5 .225
Metformin Sebelum
.199 5
.200 .903 5 .426
Hari 0 .235
5 .200
.907 5 .449 Hari 15
.239 5
.200 .947 5 .716
. This is a lower bound of the true significance. a. Lilliefors Significance Correction
Test of Homogeneity of Variances
Levene Statistic df1
df2 Sig.
Akuades 2.630
2 12
.113 Dosis_100
9.826 2
12 .003
Dosis_200 6.294
2 12
.014 Dosis_300
1.553 2
12 .251
Metformin 14.564
2 12
.001
ANOVA
Sum of Squares df Mean Square F
Sig. Akuades
Between Groups 54853.733
2 27426.867
6.391 .013 Within Groups
51496.000 12 4291.333
Total 106349.733 14
Dosis_300 Between Groups
114344.533 2
57172.267 28.556 .000 Within Groups
24025.200 12 2002.100
Total 138369.733 14
Kruskal-Wallis Test
Test Statistics
a
Dosis_100 Dosis_200
Metformin Chi-Square
11.180 12.042
9.572 df
2 2
2 Asymp. Sig.
.004 .002
.008
Universitas Sumatera Utara
d. Persentase penurunan KGD